Fulcrum Therapeutics Inc. (FULC) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Fulcrum Therapeutics Inc.

    NASDAQ: FULC · Real-Time Price · USD
    7.27
    -0.39 (-5.09%)
    At close: Sep 08, 2025, 3:59 PM
    7.20
    -0.96%
    After-hours: Sep 08, 2025, 07:30 PM EDT

    Fulcrum Therapeutics Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -29.96 -4.25 -3.1 -7.99
    PEG Ratio
    		 0.34 0.13 -0.53 0.45
    PS Ratio
    		 3.64 147.54 51.65 32.64
    PB Ratio
    		 1.20 1.76 1.65 2.96
    P/FCF Ratio
    		 -116.72 -4.52 -3.31 -7.8
    P/OCF Ratio
    		 -131.35 -4.55 -3.37 -7.97
    OCF/S Ratio
    		 -0.03 -32.43 -15.3 -4.1
    Debt / Equity Ratio
    		 0.04 0.05 0.07 n/a
    Quick Ratio
    		 22.63 17.71 12.46 11.80
    Current Ratio
    		 22.63 17.71 12.41 11.77
    Asset Turnover
    		 0.31 0.01 0.03 0.08
    Interest Coverage
    		 n/a n/a n/a n/a
    Return on Equity
    		 -0.04 -0.41 -0.53 -0.37
    Return on Assets
    		 -0.04 -0.38 -0.47 -0.33
    Return on Invested Capital
    		 -0.09 -0.45 -0.5 -0.36
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 0.98 1.00 0.62 0.87
    Net Profit Margin
    		 -0.12 -34.7 -16.65 -4.09
    Pretax Profit Margin
    		 -0.12 -34.7 -17.32 -4.22
    Operating Profit Margin
    		 -0.27 -39.45 -17.75 -4.23
    FCF Margin
    		 -0.03 -32.61 -15.61 -4.18
    EBITDA Margin
    		 -0.23 -38.68 -17.3 -4.1

    Add to Watchlist